Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF- binding protein-3 concentrations in normal children and children with growth hormone deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 82-89

  Kawai, Nobuyasu ^a,b   Kanzaki, Susumu ^a   Takano Watou, Syouko ^a   Tada, Chiaki ^a   Yamanaka, Yoshitaka ^a   Miyata, Tsuyoshi ^c   Oka, Masanori ^d   Seino, Yoshiki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Japanese Red Cross Okayama Hospital   (Japan)

^c Cosmic Corp Inc ^*  (Japan)

^d SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; BONE GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH ACCELERATION; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; INFANCY; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; ADULT; AGE FACTORS; BODY HEIGHT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 0032926738     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.82     Document Type: Article

References (50)

1. 1. Schoenle E, Zapf J, Humbel RE, Froesch ER. 1982 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 296:252-253.
2. 2. Underwood LE, Van Wyk JJ. 1992 Normal and aberrant growth. In: Wilson JD, Foster DW, eds. Williams' textbook of endocrinology, 8th ed. Philadelphia: Saunders; 1079-1138.
3. 3. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. 1993 Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 76:1610-1616.
4. 4. Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
5. 5. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
6. 6. Rosenfeld RG, Pham H, Cohen P, et al. 1994 Insulin-like growth factor binding proteins and their regulation. Acta Paediatr. 83(Suppl 899):154-158.
7. 7. Rajaram S, Baylink DJ, Mohan S. 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 18:801-831.
8. 8. Daughaday WH, Ward AP, Goldberg AC, Trivedi B, Kapadia M. 1982 Characterisation of somatomedin binding in human serum by ultracentrifugation and gel filtration. Clin Endocrinol Metab. 55:916-921.
9. 9. Guler HP, Zapf J, Schmid C, Froesch ER. 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
10. 10. Hardouin S, Gourmelen M, Noguiez P, et al. 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab. 69:1291-1301.
11. 11. Baxter RC, Martin JL. 1989 Structure of the M 140,000 growth hormone dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci USA. 86:6898-6902.
12. 12. Collett-Solberg PF, Cohen P. 1996 The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am. 25:591-614.
13. 13. Hizuka N, Takano K, Asakawa K, et al. 1991 Measurement of free form of Insulin-like growth factor I in human plasma. Growth Regul. 1:51-55.
14. 14. Frystyk J, Skjærbaek C, Dinesen B, Ørskov H. 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
15. 15. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. 1994 Measurement of free insulin-like growth factor-I using immunoradiometric assay. J Immunoassay. 15:263-276.
16. 16. Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y. 1996 Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol. 134:184-189.
17. 17. Juul A, Flyvbjerg A, Frystyk J, Muller J, Skakkebæk NE. 1996 Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf)-44:515-523.
18. 18. Hasegawa Y, Hasegawa T, Fujii K, et al. 1997 High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab. 82:156-158.
19. 19. Juul A, Holm K, Kastrup KW, et al. 1997 Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab. 82:2497-2502.
20. 20. Skjæbæk C, Vahl N, Frystyk J, et al. 1997 Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement. Eur J Endocrinol. 137:132-137.
21. 21. Juul A, Dalgaard P, Blum WF, et al. 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 80:2534-2542.
22. 22. Lee PDK, Powell D, Baker B, et al. Characterization of a direct, non extraction immunoradiometric assay for free IGF-I [Abstract 939]. Proc of the 76th Annual Meet of The Endocrine Soc. 1994; 435.
23. 23. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. 1977 Estimation of somatomedin-C levels in normals and patients with pituitary and patients with pituitary disease by radioimmunoassay. J Clin Invest. 60:648-657.
24. 24. D'Ercole AJ, Underwood LE, Van Wyk JJ. 1977 Serum somatomedin-C in hypopituitarism and in other disorders of growth. J Pediatr. 90:375-381.
25. 25. Underwood LE, D'Ercole AJ, Van Wyk JJ. 1980 Somatomedin-C and the assessment of growth. Pediatr Clin North Am. 27:771-782.
26. 26. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL. 1986 Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr. 109:428-433.
27. 27. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
28. 28. Lee PDK, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG. 1990 Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing. Pediatr Res. 27:45-51.
29. 29. Hasegawa Y, Hasegawa T, Aso T, et al. 1993 Comparison between insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) measurement in the diagnosis of growth hormone deficiency. Endocr J. 40:185-190.
30. 30. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. 1993 Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab. 77:1294-1299.
31. 31. Adan L, Souberbielle J, Brauner R. 1994 Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab. 78:353-358.
32. 32. Hasegawa Y, Hasegawa T, Aso T, et al. 1994 Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol. 131:27-32.
33. 33. Nunez SB, Municchi G, Barnes KM, Rose SR. 1996 Insulin-like growth factor I (IGF-I) and IGF-bindingprotein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children - a clinical research center study. J Clin Endocrinol Metab. 81:1927-1932.
34. 34. Tillmann V, Buckler JM, Kibirige MS, et al. 1997 Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab. 82531-535.
35. 35. Daughaday WH, Mariz IK, Blethen SL. 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 51:781-788.
36. 36. Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S. 1992 Longitudinal standards for height and height velocity for Japanese children. Clin Pediatr Endocrinol. 1:5-13.
37. 37. Juul A, Hertel NT, Main K, et al. 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 78:744-752.
38. 38. Olivie MAA, Garcia-Mayor RV, Leston DG, et al. 1995 Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study. Pediatr Res. 38:149-155.
39. 39. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y. 1995 Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone. 17:397-401.
40. 40. Tobiume H, Kanzaki S, Hida S, et al. 1997 Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab. 82:2056-2061.
41. 41. Rivarola MA, Phillips III JA, Migeon CJ, Heinrich JJ, Hjelle BJ. 1984 Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A. J Clin Endocrinol Metab. 59:34-40.
42. 42. Savage MO, Blum WF, Ranke MB, et al. 1993 Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab. 77:1465-1471.
43. 43. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 10:68-91.
44. 44. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S. 1995 Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab. 80:190-194.
45. 45. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, Van Der Veen E. 1996 Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab. 81:1371-1377.
46. 46. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S. 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab. 81:2111-2116.
47. 7. Schimpff RM, Donnadieu M, Gourmelen M, Girard F. 1974 The effects of hGH treatment on somatomedin levels in the serum (as determined by 35-S uptake into cartilage). Horm Metab Res. 6:494-498.
48. 48. Kastrup KW, Andersen H, Eskildsen PC, Jacobsen BB, Krabbe S, Petersen KE. 1979 Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment. Acta Paediatr Scand. 277(Suppl):8-13.
49. 49. Rosenfeld RG, Kemp SF, Hintz RL. 1981 Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab. 53:611-617.
50. 50. D'Ercole AJ. 1989 Somatomedins/insulin-like growth factors. In: Brook CGD, ed. Clinical paediatric endocrinology, 2nd ed. Oxford: Blackwell; 74-95.